| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 971 | 2021 |
| Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ... Nature medicine 27 (12), 2127-2135, 2021 | 611 | 2021 |
| Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae TA Russo, R Olson, CT Fang, N Stoesser, M Miller, U MacDonald, ... Journal of clinical microbiology 56 (9), 10.1128/jcm. 00776-18, 2018 | 468 | 2018 |
| Multilocus Sequence Typing of Clostridium difficile D Griffiths, W Fawley, M Kachrimanidou, R Bowden, DW Crook, R Fung, ... Journal of clinical microbiology 48 (3), 770-778, 2010 | 462 | 2010 |
| Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data N Stoesser, EM Batty, DW Eyre, M Morgan, DH Wyllie, C Del Ojo Elias, ... Journal of Antimicrobial Chemotherapy 68 (10), 2234-2244, 2013 | 328 | 2013 |
| Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta, ... Nature medicine 27 (8), 1370-1378, 2021 | 318 | 2021 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 316 | 2020 |
| Effects of control interventions on Clostridium difficile infection in England: an observational study KE Dingle, X Didelot, TP Quan, DW Eyre, N Stoesser, T Golubchik, ... The Lancet Infectious Diseases 17 (4), 411-421, 2017 | 310 | 2017 |
| Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials DW Crook, AS Walker, Y Kean, K Weiss, OA Cornely, MA Miller, ... Clinical Infectious Diseases 55 (suppl_2), S93-S103, 2012 | 304 | 2012 |
| Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131 N Stoesser, AE Sheppard, L Pankhurst, N De Maio, CE Moore, R Sebra, ... MBio 7 (2), 10.1128/mbio. 02162-15, 2016 | 298 | 2016 |
| The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections—a systematic review of the literature AE Kizny Gordon, AJ Mathers, EYL Cheong, T Gottlieb, S Kotay, ... Clinical Infectious Diseases 64 (10), 1435-1444, 2017 | 294 | 2017 |
| Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom J Wei, N Stoesser, PC Matthews, D Ayoubkhani, R Studley, I Bell, JI Bell, ... Nature microbiology 6 (9), 1140-1149, 2021 | 281 | 2021 |
| Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPC AE Sheppard, N Stoesser, DJ Wilson, R Sebra, A Kasarskis, LW Anson, ... Antimicrobial agents and chemotherapy 60 (6), 3767-3778, 2016 | 279 | 2016 |
| Identifying lineage effects when controlling for population structure improves power in bacterial association studies SG Earle, CH Wu, J Charlesworth, N Stoesser, NC Gordon, TM Walker, ... Nature microbiology 1 (5), 1-8, 2016 | 277 | 2016 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 271 | 2020 |
| Comparison of long-read sequencing technologies in the hybrid assembly of complex bacterial genomes N De Maio, LP Shaw, A Hubbard, S George, ND Sanderson, J Swann, ... Microbial genomics 5 (9), e000294, 2019 | 226 | 2019 |
| Plasmid classification in an era of whole-genome sequencing: application in studies of antibiotic resistance epidemiology A Orlek, N Stoesser, MF Anjum, M Doumith, MJ Ellington, T Peto, D Crook, ... Frontiers in microbiology 8, 182, 2017 | 199 | 2017 |
| Clinical Clostridium difficile: clonality and pathogenicity locus diversity KE Dingle, D Griffiths, X Didelot, J Evans, A Vaughan, M Kachrimanidou, ... PloS one 6 (5), e19993, 2011 | 187 | 2011 |
| Evolutionary History of the Clostridium difficile Pathogenicity Locus KE Dingle, B Elliott, E Robinson, D Griffiths, DW Eyre, N Stoesser, ... Genome biology and evolution 6 (1), 36-52, 2014 | 185 | 2014 |
| COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing T Peto, D Affron, B Afrough, A Agasu, M Ainsworth, A Allanson, K Allen, ... EClinicalMedicine 36, 2021 | 184 | 2021 |
